Treated with a stable dose of one of the following for at least 3 months prior to screening: * >=1000 mg/day immediate-release metformin; or metformin >=1000 mg/day and sulfonylurea; or sulfonylurea/metformin combination therapy. 
HbA1c between 7.1% and 11.0%, inclusive. 
Body Mass Index (BMI) >21 kg/m^2 and <35 kg/m^2. 
